|
|
||||||||
Department of Histology and Medical Embryology, University of Rome La Sapienza, 00161, Rome, Italy
1Correspondence: Department of Histology and Medical Embryology, University of Rome La Sapienza, Via A. Scarpa 14, 00161, Rome, Italy. E-mail: bouche{at}uniroma1.it
Transforming growth factor ß (TGF) is a well-known inhibitor of myogenic differentiation as well as an autocrine product of rhabdomyosarcoma cells. We studied the role of the TGF-ß autocrine loop in regulating growth and myogenic differentiation in the human rhabdomyosarcoma cell line, RD. We previously reported that the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) induces growth arrest and myogenic differentiation in these cells, which constitutively express muscle regulatory factors. We show that TPA inhibits the activation of secreted latent TGF-ß, thus decreasing the concentration of active TGF-ß to which the cells are exposed. This event is mediated by the TPA-induced alteration of the uPA/PAI serine-protease system. Complete removal of TGF-ß, mediated by the ectopic expression of a soluble type II TGF-ß receptor dominant negative cDNA, induces growth arrest, but does not trigger differentiation. In contrast, a reduction in the TGF-ß concentration, to a range of 0.140.20 x 10-2 ng/ml (which is similar to that measured in TPA-treated cells), mimics TPA-induced differentiation. Taken together, these data demonstrate that cell growth and suppression of differentiation in rhabdomyosarcoma cells require overproduction of active TGF-ß; furthermore, they show that a critical concentration of TGF-ß is necessary for myogenic differentiation to occur, whereas myogenesis is abolished below and above this concentration. By impairing the TGF-ß autocrine loop, TPA stabilizes the factor concentration within the range compatible for differentiation to occur. In contrast, in human primary muscle cells a much higher concentration of exogenous TGF-ß is required for the differentiation inhibitory effect and TPA inhibits differentiation in these cells probably through a TGF-ß independent mechanism. These data thus clarify the mechanism underlying the multiple roles of TGF-ß in the regulation of both the transformed and differentiated phenotype.Bouché, M., Canipari, R., Melchionna, R., Willems, D., Senni, M. I., Molinaro, M. TGF-ß autocrine loop regulates cell growth and myogenic differentiation in human rhabdomyosarcoma cells.
Key Words: TPA serine-protease system muscle regulatory factors RD cells
This article has been cited by other articles:
![]() |
S. Croci, L. Landuzzi, A. Astolfi, G. Nicoletti, A. Rosolen, F. Sartori, M. Y. Follo, N. Oliver, C. De Giovanni, P. Nanni, et al. Inhibition of Connective Tissue Growth Factor (CTGF/CCN2) Expression Decreases the Survival and Myogenic Differentiation of Human Rhabdomyosarcoma Cells Cancer Res., March 1, 2004; 64(5): 1730 - 1736. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, S. R. Thomson, J. D. Starkey, J. L. Page, A. D. Ealy, and S. E. Johnson Transforming Growth Factor {beta}1 Is Up-regulated by Activated Raf in Skeletal Myoblasts but Does Not Contribute to the Differentiation-defective Phenotype J. Biol. Chem., January 23, 2004; 279(4): 2528 - 2534. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. L. Loducca, A. Mantesso, E. M. F. De Oliveira, and V. C. De Araujo Intraosseous Rhabdomyosarcoma of the Mandible: A Case Report International Journal of Surgical Pathology, January 1, 2003; 11(1): 57 - 60. [Abstract] [PDF] |
||||
![]() |
A. Mauro, C. Ciccarelli, P. De Cesaris, A. Scoglio, M. Bouche, M. Molinaro, A. Aquino, and B. M. Zani PKC{alpha}-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells J. Cell Sci., September 15, 2002; 115(18): 3587 - 3599. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |